Home > News > featured news > Compulink Receives 21st Century Cures Act Certification From ONC

HEALTH TECHNOLOGY, FUTURE OF HEALTHCARE

Compulink Receives 21st Century Cures Act Certification From ONC

Compulink Healthcare Solutions | January 03, 2023 | Read time : 01:00 min

Compulink Receives
As the market leader in specialty-specific, all-in-one EHR solutions, Compulink Healthcare Solutions has earned the ONC-Health IT 2015 Edition Cures Update Health IT certification that will come into effect in 2023. This includes the most recent interoperability standards essential for supporting compliance with the information-sharing requirements of the 21st Century Cures Act.

Compulink said that getting certified early shows how committed they are to making sure that their clients' solutions are in line with the many rules that require the use of certified EHR technology.

Compulink Advantage™ is an all-in-one database EHR solution that provides its clients with practice management, inventory management, patient portal, mobile patient engagement, ASC, E-Commerce, analytics, optical POS (for eyecare practices), and a billing (RCM) service option. The company offers complete EHR solutions for ophthalmology, optometry, orthopedics, otolaryngology, behavioral health, dermatology, gastroenterology, podiatry, pain management, physical therapy, audiology, and urology.

Drummond Group LLC, an authorized certification body, certified Compulink's EHR products (ACB). Drummond, testing for more than 20 years, has done more than 3,000 tests and certifications for health IT since 2010.

About the Certification
Compulink Advantage Version 12 complies with the 2015 Edition. It has been approved as such by an ONC-ACB based on the criteria for certification set by the Secretary of Health and Human Services. This certification does not mean that the United States Department of Health and Human Services backs the product or service in question.

About the Compulink Healthcare Solutions


Compulink Healthcare Solutions all-in-one EHR and practice management solution has helped specialty medical practices reduce costs, increase efficiency, and simplify the delivery of excellent patient care. Compulink is the leader in fully customizable EHR solutions that adapt to your practice style and is used by over 26,000 providers in over 4,700 locations, 70 ambulatory surgical centers, and 19 colleges and universities.

Spotlight

The impact of the U.S. embargo on Cuban healthcare

Cuba has been under a U.S. trade embargo for more than 60 years, which has negatively impacted major social and economic services.

More featured news

Spotlight

The impact of the U.S. embargo on Cuban healthcare

Cuba has been under a U.S. trade embargo for more than 60 years, which has negatively impacted major social and economic services.

Related News

HEALTH TECHNOLOGY, FUTURE OF HEALTHCARE

Juvare Introduces Data Automation Process from EMResource to NHSN

Juvare | December 28, 2022

A leader in crisis and emergency management technology, Juvare recently announced successfully automating the transfer of hospital bed capacity data from EMResource to National Healthcare Safety Network (NHSN), run by Centers for Disease Control and Prevention (CDC). EMResource data has been used as part of the national response to COVID-19 since the beginning of the pandemic. This has enabled flexible data collection from hospitals and improved visibility at both the state and federal levels. According to estimates, data obtained from EMResource served as the single most important source for hospital information. “McKinsey Institute estimates that automating different tasks can raise productivity growth to 1.4% annually” The company believes that the ability to quickly help hospitals and public health stakeholders keep track of the situation across a region or state and respond to changing regulatory needs without giving healthcare providers more work is a unique feature. Even when there are no federal rules or requirements, EMResource helps states and healthcare coalitions keep track of the capacity and availability of healthcare resources. During the pandemic, Juvare made a number of important changes to the EMResource platform. For example, it updated the user interface and gave hospitals across the state access to APIs so that they could automate data in a way that had never been done before. Also, the company launched the JX Connector integration platform to help the public sector update its digital systems by quickly connecting different data streams. The integration of EMResource and NHSN was done faster with Juvare's JX Connector, a platform for integration-as-a-service. About Juvare Juvare Enterprise Resilience Solutions help organizations connect to the important resources, data, and mutual help they need to bounce back after disasters or other problems. Juvare has helped with over 500,000 emergency response situations each year in more than 25 countries.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

Ventra Health Acquires Deras Global, Expands to Philippines

Ventra Health | February 22, 2023

On February 21, 2023, Ventra Health, a leading revenue cycle management company, announced that it has successfully acquired Deras Global Services, a dependable provider of RCM services for hospital-based physician specialties based in the Philippines. Ventra Health is a technology-driven company providing practice management and advisory services, in addition to RCM, for hospital-based physician specialties. This acquisition enables Ventra Health's entry into the Philippine market, expanding its global footprint and enhancing its capabilities in delivering RCM services. In addition, this marks a significant milestone in Ventra Health's global workforce development and service-delivery strategy. The transaction is another successful move in a busy first quarter for the renowned Physician RCM platform. Steven Huddleston, Ventra Health CEO, shared, "Moving fast on accretive opportunities that enhance client delivery and growth is my top priority. We will continue to move aggressively when opportunities present themselves." (Source – Cision PR Newswire) Ventra Health's acquisition of Deras Global Services marks the company's expansion of its global presence, bringing its services to the Clark Freeport and Special Economic Zone. With over 300 employees and additional capacity for future growth, this acquisition represents a significant expansion of Ventra Health's operations in the region. About Ventra Health Ventra Healthis a leading provider of high-performance business solutions for physician practices, hospitals, and health systems, specializing in anesthesia, emergency medicine, and hospital medicine. The company partners with private practices, hospitals, health systems, and physician management organizations to deliver innovative solutions that solve healthcare providers' most complex revenue and reimbursement challenges. Its comprehensive range of solutions includes revenue generation, finance and operations, workflow re-engineering, and healthcare trend insight. Founded in 2021, Ventra Health is the result of a merger between Abeo, DuvaSawko, and Gottlieb, three prominent revenue cycle management companies in their respective fields.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

Body Vision Medical's Lungvision™ Validated by Xoran Technologies' Tron™ System

Body Vision Medical | February 15, 2023

Body Vision Medical, a leading AI-driven, intraoperative CT imaging provider, and Xoran Technologies, an innovator in low-dose, point-of-care CT systems, recently announced the successful validation of Body Vision's LungVisionTM system with Xoran's TRONTM system. The LungVisionTM system from Body Vision uses artificial intelligence (AI) to convert X-ray images from any C-arm into intraoperative, real-time CT scans. This enables bronchoscopists to obtain biopsies from smaller, harder-to-access lung lesions at an earlier stage, thereby improving lung cancer patients' chances of early diagnosis and survival. TRONTM is a mobile, full-body fluoroscopy, computed tomography (CT) X-ray system created to provide safe, ultra-high-resolution, low-dose imaging directly in point-of-care settings, including the surgery center, operating room, and critical care units, thus avoiding risky patient transport to Radiology for CT imaging, and aiding minimally invasive procedures (MIS). David Webster, CEO of Body Vision Medical, shared, "Body Vision's approach with LungVision™ is to ensure that it works with existing equipment so that we empower healthcare providers to better serve a growing population of lung patients without ballooning overall operating costs." He added, "While our rapidly growing installed base is real-world evidence that our technology integrates seamlessly with any 2D/3D X-ray imaging system, for customers seeking added assurance, this formal validation of Xoran TRON™ for use with LungVision™ is one of several steps we are proactively taking to ensure consistency in system performance regardless of setup." (Source – PR Newswire) About Body Vision Body Vision Medical is a commercial-stage medical device company founded in 2014 and based in Campbell, California. It specializes in real-time, intraoperative imaging powered by artificial intelligence. LungVisionTM, the company's first commercial product, addresses the unmet clinical requirement for early, definitive lung cancer diagnosis and, in the future, will enable minimally invasive treatment of lung lesions. In addition, the company continues to establish a new standard of care for lung diagnostics through the ongoing collaboration of physicians, clinical experts, and engineers with diverse backgrounds.

Read More

HEALTH TECHNOLOGY, FUTURE OF HEALTHCARE

Juvare Introduces Data Automation Process from EMResource to NHSN

Juvare | December 28, 2022

A leader in crisis and emergency management technology, Juvare recently announced successfully automating the transfer of hospital bed capacity data from EMResource to National Healthcare Safety Network (NHSN), run by Centers for Disease Control and Prevention (CDC). EMResource data has been used as part of the national response to COVID-19 since the beginning of the pandemic. This has enabled flexible data collection from hospitals and improved visibility at both the state and federal levels. According to estimates, data obtained from EMResource served as the single most important source for hospital information. “McKinsey Institute estimates that automating different tasks can raise productivity growth to 1.4% annually” The company believes that the ability to quickly help hospitals and public health stakeholders keep track of the situation across a region or state and respond to changing regulatory needs without giving healthcare providers more work is a unique feature. Even when there are no federal rules or requirements, EMResource helps states and healthcare coalitions keep track of the capacity and availability of healthcare resources. During the pandemic, Juvare made a number of important changes to the EMResource platform. For example, it updated the user interface and gave hospitals across the state access to APIs so that they could automate data in a way that had never been done before. Also, the company launched the JX Connector integration platform to help the public sector update its digital systems by quickly connecting different data streams. The integration of EMResource and NHSN was done faster with Juvare's JX Connector, a platform for integration-as-a-service. About Juvare Juvare Enterprise Resilience Solutions help organizations connect to the important resources, data, and mutual help they need to bounce back after disasters or other problems. Juvare has helped with over 500,000 emergency response situations each year in more than 25 countries.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

Ventra Health Acquires Deras Global, Expands to Philippines

Ventra Health | February 22, 2023

On February 21, 2023, Ventra Health, a leading revenue cycle management company, announced that it has successfully acquired Deras Global Services, a dependable provider of RCM services for hospital-based physician specialties based in the Philippines. Ventra Health is a technology-driven company providing practice management and advisory services, in addition to RCM, for hospital-based physician specialties. This acquisition enables Ventra Health's entry into the Philippine market, expanding its global footprint and enhancing its capabilities in delivering RCM services. In addition, this marks a significant milestone in Ventra Health's global workforce development and service-delivery strategy. The transaction is another successful move in a busy first quarter for the renowned Physician RCM platform. Steven Huddleston, Ventra Health CEO, shared, "Moving fast on accretive opportunities that enhance client delivery and growth is my top priority. We will continue to move aggressively when opportunities present themselves." (Source – Cision PR Newswire) Ventra Health's acquisition of Deras Global Services marks the company's expansion of its global presence, bringing its services to the Clark Freeport and Special Economic Zone. With over 300 employees and additional capacity for future growth, this acquisition represents a significant expansion of Ventra Health's operations in the region. About Ventra Health Ventra Healthis a leading provider of high-performance business solutions for physician practices, hospitals, and health systems, specializing in anesthesia, emergency medicine, and hospital medicine. The company partners with private practices, hospitals, health systems, and physician management organizations to deliver innovative solutions that solve healthcare providers' most complex revenue and reimbursement challenges. Its comprehensive range of solutions includes revenue generation, finance and operations, workflow re-engineering, and healthcare trend insight. Founded in 2021, Ventra Health is the result of a merger between Abeo, DuvaSawko, and Gottlieb, three prominent revenue cycle management companies in their respective fields.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

Body Vision Medical's Lungvision™ Validated by Xoran Technologies' Tron™ System

Body Vision Medical | February 15, 2023

Body Vision Medical, a leading AI-driven, intraoperative CT imaging provider, and Xoran Technologies, an innovator in low-dose, point-of-care CT systems, recently announced the successful validation of Body Vision's LungVisionTM system with Xoran's TRONTM system. The LungVisionTM system from Body Vision uses artificial intelligence (AI) to convert X-ray images from any C-arm into intraoperative, real-time CT scans. This enables bronchoscopists to obtain biopsies from smaller, harder-to-access lung lesions at an earlier stage, thereby improving lung cancer patients' chances of early diagnosis and survival. TRONTM is a mobile, full-body fluoroscopy, computed tomography (CT) X-ray system created to provide safe, ultra-high-resolution, low-dose imaging directly in point-of-care settings, including the surgery center, operating room, and critical care units, thus avoiding risky patient transport to Radiology for CT imaging, and aiding minimally invasive procedures (MIS). David Webster, CEO of Body Vision Medical, shared, "Body Vision's approach with LungVision™ is to ensure that it works with existing equipment so that we empower healthcare providers to better serve a growing population of lung patients without ballooning overall operating costs." He added, "While our rapidly growing installed base is real-world evidence that our technology integrates seamlessly with any 2D/3D X-ray imaging system, for customers seeking added assurance, this formal validation of Xoran TRON™ for use with LungVision™ is one of several steps we are proactively taking to ensure consistency in system performance regardless of setup." (Source – PR Newswire) About Body Vision Body Vision Medical is a commercial-stage medical device company founded in 2014 and based in Campbell, California. It specializes in real-time, intraoperative imaging powered by artificial intelligence. LungVisionTM, the company's first commercial product, addresses the unmet clinical requirement for early, definitive lung cancer diagnosis and, in the future, will enable minimally invasive treatment of lung lesions. In addition, the company continues to establish a new standard of care for lung diagnostics through the ongoing collaboration of physicians, clinical experts, and engineers with diverse backgrounds.

Read More

More featured news